Growing dental disorders and dominance of implantology to drive the Dental Biomaterials Market

DataM Intelligence announces its market report titled “Global Dental Biomaterials Market – Size, Share and Forecasts (2019-2026)” which reflects the size, share, forecast analysis of key players. The report analyses market dynamics to provide market opportunities.
Dental biomaterials are specialized natural or synthetic products designed to be used in the preventive and restorative dentistry. According to the World Health Organization (WHO), dental disorders are one of the major public health issues in most of the developed and developing countries. Most of the oral diseases are considered as noncommunicable diseases. The most common oral diseases include untreated caries in permanent teeth, untreated caries in deciduous teeth, and severe periodontitis in adults.
In developed countries, dental disorders affect 60% to 90% of children and 5% to 20% of middle-aged adults. Dental biomaterials are the primary choice of dentists in restructuring and preventing the teeth and gum damage.
Get a free sample of the report - https://www.datamintelligence.com/research-report/dental-biomaterials-market
Global Dental Biomaterials Market Drivers
The market is driven by the growing prevalence of dental disorders, rising geriatric population, increasing demand for cosmetic dentistry, increase in expenditure on dental and oral care and increasing adoption of novel adhesives, resin cement in CAD/CAM and other digital technologies. Dental CAD/CAM technology includes the use of new materials and data acquisition. It is a non-destructive method of saving impressions, restorations, and information in a computer and acts as a communication tool for evaluation.
The rise in disposable income and dentists especially in developing countries is another key factor for the market growth. For instance, according to the Brazilian Institute of Geography and Statistics (IBGE), in 2019, Brazil has 174,000 dentists, which corresponds to 11% of the world’s total population. Implementation of favourable policies and initiatives are also on the rise in most of the developing countries. In US dental expenditure is increasing because of awareness, rise in disposable income and inclination towards cosmetic dentistry.
Global Dental Biomaterials Market Restraints
The high cost of treatment, presence of stringent regulatory and clinical processes and low reimbursement coverage by insurance are going to restrain the market in the forecast period. According to the WHO, every year oral diseases are among the most expensive diseases to be treated in developing as well as developed countries. According to the Organization for Economic Co-operation and Development (OECD), In developing, nations large chunk of dental care is spent out of pocket, for instance in China, current basic medical insurance only covers a small portion of dental care expenditures, and over 85% of total dental costs are paid out of pocket.
In developed countries too, dental expenditures are not predominantly covered by the government. For instance, in the US dental expenditure is minimally covered by CMS or other private organizations, but the majority of it is paid out of pocket. In 2017, Medicaid coverage for dental services accounted for $12.5 billion whereas out-of-pocket expenditure accounted for 53.0 billion.
Global Dental Biomaterials Market Segmentation Analysis
The global dental biomaterials market can be segmented by product as bone graft materials, dental membranes, and soft tissue regeneration products, by type as metallic, ceramic, and natural dental biomaterials, by application as implantology, periodontology, prosthodontics, orthodontics, and others and by end user as dental implant and prosthetic manufacturers, dental laboratories, dental hospitals and clinics, and dental academies and research institutes.
By type, polymeric biomaterials are expected to dominate the market during the period of forecast because of high product durability, reduced risks of infections compared to other materials, material flexibility that provides ease in shape formation, biocompatibility, good resilience, lightweight, easy fabrication, and high corrosion resistance. Moreover, polymeric biomaterials have unique antimicrobial and drug delivery properties in preventive, regenerative, and restorative therapies to reduce friction and corrosion in dentistry.
By application, implantology is the highest growing segment in the dental biomaterials market due to increasing demand for dental implants as it transmits mechanical forces and stimulation into the jawbone and provides patients with natural activities of teeth. According to the American Academy of Implant Dentistry, in 2018, around 150 million people in the US were missing at least one tooth and around five million underwent dental restoration and it is growing annually by 500,000.
Global Dental Biomaterials Market Regional Analysis
Geographically, the global dental biomaterials market is divided into North America, Europe, South America, Asia-Pacific and the Middle East and Africa.
North America is anticipated to account for a significant share of the global market over the period of forecast, owing to an increase in the geriatric population in the country. According to the American College of Prosthodontists (ACP), in 2018, around 23 million people in the US were completely edentulous and another 12 million are edentulous in one arch.
The market in the Asia Pacific is likely to expand at a significant CAGR during the forecast period. Increase in the geriatric population with missing teeth and rise in demand for aesthetics leading to higher adoption of dental implants are projected to boost the dental biomaterials market in the region. According to the Indian Dental Association (IDA), in 2018, about 30% of adults aged 65 years and older in India are edentulous, compared to 46% of the population 20 years ago, this is owing to higher adoption of dental biomaterial implants. The prevalence in China is significantly high. According to 4th national oral health epidemiology survey, the percent of periodontally healthy people in middle-aged and elderly population category is just 12.6%.
Favourable government initiatives in APAC countries will have a positive impact on the APAC dental biomaterials market. It includes policies for healthy lifestyles, optimization of health industries and improvement of health services including dental care. Recently, the Chinese Academy of Engineering (CAE) launched a strategic analysis project, ‘The oral health management of China in 2035’. The initiative aims to analyze international trends in oral health promotion and identify the advantages and disadvantages of current oral health management measures in China and to identify frontiers for the competitive development of oral health in China.

Global Dental Biomaterials Market Company Trends
Some of the major key players in the market are Straumann AG, Geistlich Pharma AG, Zimmer Biomet Holdings, Inc., Danaher Corporation, Dentsply Sirona, Inc., 3M Company, Royal DSM, Kuraray Co., Ltd, Medtronic Plc., Henry Schein, Inc., Mitsui Chemicals ,Inc., Victrex Plc, Ivoclar Vivadent AG, GC Corporation, Keystone Dental, Inc., Datum Dental Ltd, BEGO Medical GmbH, Cam Bioceramics B.V., Geistlich Pharma AG, BioHorizons IPH, Inc., and Biomatlante. Few of the recent key developments of the major players are list below –
In March 2019, Dentsply Sirona Implants unveiled two innovations in implant dentistry - Azento and Acuris to help dentistry professionals with single tooth replacement.
In January 2019, Dentsply Sirona and Carbon announced strategic collaboration to deliver denture materials for Carbon digital 3D printing production solutions.
In December 2018, Straumann Group entered a strategic partnership with Z-Systems. By the agreement, Straumann obtained exclusive distribution rights in most major markets for Z-Systems’ next generation implant line, which complements the Group’s current PURE ceramic implant range.
In October 2018, Straumann Group launched innovative fully-tapered implant, BLX and New Straumann® PURE two-piece ceramic implant that simplifies handling and adds flexibility.
In September 2018, Straumann Group signed agreements to buy further shares in T-Plus, the Taiwanese dental implant manufacturer, in order to gain a controlling stake in the company. The shares will be purchased from existing shareholders, increasing the Group’s ownership from 49% to up to 60%.
In September 2018, Henry Schein, Inc. acquired Intra-Lock, a provider of dental restoration solutions. This will enhance its position in the premium implant segment.
In July 2018, Straumann Group acquired a 30% stake in its biomaterials partner, Botiss medical AG. This acquisition enables Straumann to expand its dental biomaterials portfolio.
In July 2018, Straumann Group increased its stake in Createch Medical, a provider of high-precision CADCAM dental prosthetics, from 30% to full ownership for a purchase consideration of approximately $14 million.
In July 2018, Danaher Corporation announced to spin off its dental segment into an independent, publicly-traded company "DentalCo". The transaction is intended to be tax-free to Danaher shareholders and expected to be completed in the second half of 2019.

To know more about Global Dental Biomaterials Market - https://www.datamintelligence.com/research-report/dental-biomaterials-market

About DataM Intelligence
DataM Intelligence 4Market Research is a Market Intelligence and Business Research firm, based in India. It aims to bridge the two main aspects of a business decision - opinion and supportive data.

Market Research for long has been losing its credibility owing to low reliability and high proportions of estimations. Having identified this gap, DataM was established to provide businesses with reliable and near-market intelligence. Reporting the actual market scenario has been made possible by our proprietary methodology, that essentially revolves around gathering inputs from industry participants and integrating the trends into statistical Databank. This approach not only aligns the findings with historical data but also allows a highly justifiable forecast model.

Corporate Address
1st floor, Phoenix Tech Tower, Plot no: 14/46, Habsidguda, IDA-Uppal, Hyderabad-500039, Telangana

Email
info@datamintelligence.com

Phone
+1 877-441-4866

This release was published on openPR.